Clinical Trial Update: Dopaminergic Modulation of Declarative Memory [Phase 4]

View source ↗

Summary

Phase 4 clinical trial on dopaminergic modulation of declarative memory in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: I.R.C.C.S. Fondazione Santa Lucia | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED